ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

CTCs Do Not Affect Survival, But Could Signal Metastases

December 30, 2011

Evidence “Weak” Linking EMFs, cancer

June 25, 1999

Fred Hutchinson Center Wins $140 Mil. Contract To Coordinate NIH Women’s Health Initiative

October 23, 1992

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010

Task Force Members Give Mea Culpa at Congressional Hearing

December 4, 2009

NCI Could Fund Some Challenge Grants That Miss NIH Funding, Director Says

June 26, 2009